AstraZeneca PLC/ US0463531089 /
11/06/2024 22:00:00 | Chg. -0.9800 | Volume | Bid00:56:44 | Ask00:56:44 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
79.2300USD | -1.22% | 4.22 mill. Turnover: 215.96 mill. |
79.2700Bid Size: 100 | 79.5000Ask Size: 800 | 243.97 bill.USD | - | 20.63 |
GlobeNewswire
15/05
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
13/05
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
01/04
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
25/03
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
25/03
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire
19/03
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
15/03
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
29/02
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire
16/01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire
08/01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire
04/01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, I...